Digestive endoscopy AI (polyp/lesion detection).
Three cloud-based medical devices confirmed CE marked in 2024.
Acquirer’s (Olympus) own press release.
Acquisition by Olympus (a large, independent, publicly listed medical device company) is independently verifiable.
Acquired by Olympus (via Satisfai Health); a broader AI endoscopy ecosystem launch was planned for 2025.
No independent clinical-outcomes study found in this pass.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.
Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.